Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse

Carmela Mennuni1, Stefano Ugel, Federica Mori

  • 1Istituto di Ricerca di Biologia Molecolare, Pomezia, Italy.

Cancer Research
|December 3, 2008
PubMed

Insights

Cancer vaccination targeting telomerase reverse transcriptase (TERT) shows promise. DNA vaccination with murine TERT (mTERT) effectively delayed tumor growth in mouse models, inducing antigen-specific T cell responses with no observed adverse effects.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Telomerase reverse transcriptase (TERT) is reactivated in many human cancers, making it a potential target for cancer vaccines.
  • Genetic vaccination using murine TERT (mTERT) can overcome immune tolerance and induce TERT-specific T cell responses.

Purpose of the Study:

  • To investigate the antitumor efficacy and safety of TERT-based vaccination in preclinical cancer models.
  • To evaluate the induction of immune responses following mTERT vaccination.

Main Methods:

  • Utilized TRAMP transgenic mice for prostate cancer and a carcinogen-induced model for colon cancer.
  • Administered repeated immunizations with mTERT-encoding DNA.
  • Assessed tumor progression, immunohistochemistry for TERT expression, and intratumoral T cell infiltrates.
  • Conducted postnecropsy analysis for safety assessment.

Main Results:

  • Repeated mTERT DNA vaccination significantly delayed tumor formation and progression in both prostate and colon cancer models.
  • TERT-specific CD4+ and CD8+ T cells were induced, and telomerase-specific T cells were found in tumor infiltrates of vaccinated mice.
  • Vaccination demonstrated a good safety profile with no significant adverse effects or organ damage.

Conclusions:

  • TERT vaccination elicits antigen-specific immunosurveillance and demonstrates significant antitumor efficacy in relevant preclinical models.
  • TERT represents a promising candidate antigen for the development of preventive cancer vaccines.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.